AA
ANAC

ALPS Advisors’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

ALPS Advisors’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-58,127
Closed -$6.57M – 833
2015
Q4 		$6.57M Buy
58,127
+587
+1% +$64.7K 0.06% 114
2015
Q3 		$67.7K Buy
57,540
+14,145
+33% +$1.85M 0.07% 104
2015
Q2 		$3.36M Buy
43,395
+22,053
+103% +$1.45M 0.03% 139
2015
Q1 		$1.24M Buy
+21,342
New +$906K 0.01% 176

Other funds holding ANAC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

ALPS Advisors's ANAC Position: Q1 2016 in Review

ALPS Advisors sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q1 2016, closing a stake of 58,127 shares — an estimated $6.57M sold.

ALPS Advisors first reported a position in ANAC in Q1 2015 and held it in 4 quarters. The position peaked at $6.57M in Q4 2015. 199 funds tracked by Wall St. Rank hold ANAC as of Q1 2016.

  • ALPS Advisors reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q1 2016 after selling out during the quarter.
  • ALPS Advisors sold 58,127 ANACOR PHARMACEUTICALS INC COM shares in Q1 2016, an estimated $6.57M.
  • ALPS Advisors first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2015 and held it in 4 quarters.
  • ALPS Advisors's ANACOR PHARMACEUTICALS INC COM position peaked at $6.57M in Q4 2015.
  • 199 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q1 2016.

Based on ALPS Advisors's 13F filing for Q1 2016, filed 10 May 2016.